Active Ingredient History

  • Now
Vinorelbine (trade name Navelbine) is a semi-synthetic vinca-alkaloid with a broad spectrum of anti-tumour activity. Vinorelbine is a mitotic spindle poison that impairs chromosomal segregation during mitosis. It blocks cells at G2/M. Microtubules (derived from polymers of tubulin) are the principal target of vinorelbine. Vinorelbine was developed by Pierre Fabre under licence from the CNRS in France. NAVELBINE (vinorelbine tartrate) as a single agent or in combination is indicated for the first line treatment of non small cell lung cancer and advanced breast cancer.   NCATS

  • SMILES: CCC1=C[C@@H]2CN(C1)Cc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC
  • Mol. Mass: 778.95
  • ALogP: 4.75
  • ChEMBL Molecules:
More Chemistry

Drug Pricing (per unit)


$7.8538 - $86.9732
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

5'-anhydrovinblastine | 5'-noranhydrovinblastine | 5'-nor-anhydrovinblastine | c'-norvincaleukoblastine, 3',4'-didehydro-4'-deoxy- | kw 2307 | kw-2307 | liposomal vinorelbine | navelbin | navelbine | navelbine base | nor-5'-anhydrovinblastine | noranhydrovinblastine tartrate | vinorelbin | vinorelbina | vinorelbin ditartrate | vinorelbine | vinorelbine base | vinorelbine ditartarate | vinorelbine ditartrate | vinorelbine (ditartrate) | vinorelbine ditartrate salt hydrate | vinorelbine tartrate | vinorelbinum


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue